2-Arachidonoylglycerol

2-AG is hands down the workhorse of your own cannabinoid system; it is pretty much the full agonist at CB1 and CB2, where anandamide only manages a partial nudge, so when the brain actually wants to turn the endocannabinoid dial it reaches for this molecule. The striking part is the on-demand story; it is not sitting in vesicles waiting around, it gets built from membrane lipids the instant a neuron fires hard, floats backward across the synapse to tell the upstream cell to ease off, then gets mopped up by MAGL almost immediately; that is essentially a self-limiting brake on runaway signaling, which is why it matters for pain, mood, appetite and calming down inflammation.

You do not "take" 2-AG the way you take a supplement; it is endogenous, so the practical lever people actually pull is protecting it, mostly by slowing MAGL so it hangs around longer. It is investigational as a direct therapeutic and it does have a real inflammatory side in the periphery through non-cannabinoid targets, so the enthusiasm has to stay honest; still, as the master switch of the whole system it is one of the most important molecules on this wiki.

2-AG is an endogenous signaling lipid, not a consumer supplement, and it is investigational as a therapeutic target. It is rapidly degraded by MAGL, so free levels are transient. Elevated peripheral 2-AG has documented downsides: it can promote inflammation and atherogenesis through myeloid CB2 receptors and can activate human platelets through non-CB1/CB2 (thromboxane A2) pathways, a potential pro-thrombotic effect. Strategies that raise 2-AG by chronically inhibiting MAGL can produce CB1 receptor tolerance and desensitization. It is not risk-free, and human therapeutic manipulation remains under study.